Category: Research

FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma

Background:  Neoadjuvant immunotherapy has become the new standard of care for stage III melanoma. This study sought to describe the metabolic changes seen with fludeoxyglucose-18-positron emission to…

Read more about 'FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma'...


Circulating MicroRNAs: functional biomarkers for melanoma prognosis and treatment

MicroRNAs (miRNAs) hold significant promise as circulating cancer biomarkers and unlike many other molecular markers, they can provide valuable insights that extend beyond tumour biology. The expressi…

Read more about 'Circulating MicroRNAs: functional biomarkers for melanoma prognosis and treatment'...


3D total-body photography in patients at high risk for melanoma: randomized clinical trial

Importance:   Three-dimensional (3D) total-body photography (TBP) can support clinicians in monitoring and identifying changes to skin lesions in patients at high risk of melanoma. Objective:   To as…

Read more about '3D total-body photography in patients at high risk for melanoma: randomized clinical trial'...


Cost-effectiveness analysis of 3D total-body photography for people at high risk of melanoma

Importance:  Greater use of novel digital technologies could be associated with improved health outcomes and save health care costs by detecting smaller melanomas earlier (needing less treatment) or b…

Read more about 'Cost-effectiveness analysis of 3D total-body photography for people at high risk of melanoma'...


Specific pathways and marker genes in peripheral CD4+T-cells may predetermine melanoma staging and immunotherapy resistance

Background and purpose:  Promoting adaptive immunity with ICIs has drastically improved melanoma prognosis, but not for all patients. Some cases relapse in the first few months, while others keep dura…

Read more about 'Specific pathways and marker genes in peripheral CD4+T-cells may predetermine melanoma staging and immunotherapy resistance'...


Patients with resected stage IIB/C melanoma treated with adjuvant nivolumab demonstrated stable health-related quality of life, minimal bother from side effects

Background: In the phase 3 CheckMate 76 K trial, adjuvant nivolumab significantly improved recurrence-free survival and distant metastasis-free survival versus placebo in patients with resected stage …

Read more about 'Patients with resected stage IIB/C melanoma treated with adjuvant nivolumab demonstrated stable health-related quality of life, minimal bother from side effects'...


Significant reduction in surgical interventions for melanoma in upcoming years

Melanoma surgery has evolved from elective lymph node dissection (ELND) to sentinel lymph node biopsy (SLNB) and wide local excision (WLE) margins have come down from 5 cm to nowadays 1 – 2 cm. Recent…

Read more about 'Significant reduction in surgical interventions for melanoma in upcoming years'...


Benefits of photoprotection should be taught early to children, caregivers, and parents of all skin tones

Background: Early childhood sun exposure contributes to lifetime risk of skin cancer. Many individuals from diverse ethnic backgrounds believe their skin tone confers immunity to sun damage; however,…

Read more about 'Benefits of photoprotection should be taught early to children, caregivers, and parents of all skin tones '...